☆ 4.6 Article

MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of US children

EUROPEAN JOURNAL OF PEDIATRICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Pediatrics

A New Definition for Multisystem Inflammatory Syndrome in Children

Mary Beth F. Son et al.

PEDIATRICS (2023)

添加到收藏夹

Article Immunology

Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2

Jonathan M. Cohen et al.

Summary: Little is known about the risk of multisystem inflammatory syndrome in children (MIS-C) with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in children aged 0-16 years were 56% lower during prevaccine Delta, 66% lower during postvaccine Delta, and 95% lower during the Omicron period.

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Review Infectious Diseases

Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis

Yu Wu et al.

Summary: This meta-analysis included 29 studies and 230,227 patients to assess the duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract. The pooled duration of viable virus shedding was found to be 5.16 days, and the average duration of PCR positivity was 10.82 days. The study also revealed that there was no significant difference in the duration of viable virus shedding and PCR positivity between symptomatic and asymptomatic patients. These findings have important implications for pandemic control strategies and infection control measures.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Pediatrics

Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain

Rosa Pino et al.

Summary: This is a study on the epidemiological, clinical, and laboratory characteristics of MIS-C cases in children in Catalonia, Spain. The incidence rate of MIS-C was 4.1 per million people and 273 per million SARS-CoV-2 infections. The incidence of MIS-C decreased significantly during the Omicron variant period. The clinical manifestations and severity of MIS-C were similar across different variants.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

添加到收藏夹

Article Pediatrics

Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves

Katarzyna Ptak et al.

Summary: The purpose of this study is to evaluate the rate, clinical manifestations, and management of multisystem inflammatory syndrome in children (MIS-C) during different periods of COVID-19 variant dominance. There were no significant differences in the incidence, symptoms, or treatment between the two groups. In conclusion, the clinical course of MIS-C remains similar in subsequent waves of the pandemic, but the incidence of MIS-C appears to be decreasing.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

Anastasia S. Lambrou et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Letter Medicine, General & Internal

Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel

Nitai Levy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Immunology

Multisystem Inflammatory Syndrome in Children During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta and Omicron Variant Circulation-United States, July 2021-January 2022

Allison D. Miller et al.

Summary: This study describes 2116 cases of multisystem inflammatory syndrome in children (MIS-C) reported to the Centers for Disease Control and Prevention from July 2021 to January 2022 during the Delta and Omicron circulation. The findings show that half of the MIS-C patients were aged 5-11 years, 52% received intensive care unit-level care, and 1.1% died. Only 3.0% of eligible patients were fully vaccinated prior to MIS-C onset.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Letter Medicine, General & Internal

Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19

Jeremy Samuel Faust et al.

Summary: This modelling study estimates the excess deaths caused by COVID-19 disease in Massachusetts during the Delta and Omicron waves.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States

Michael Melgar et al.

MMWR Recommendations and Reports (2022)

添加到收藏夹

Article Immunology

The Impact of SARS-CoV-2 Variants on the Clinical Phenotype and Severity of Multisystem Inflammatory Syndrome in Children in South Africa

Deepthi Raju Abraham et al.

Summary: The clinical phenotype of MIS-C remains severe and stable across different SARS-CoV-2 variants in South African children.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

添加到收藏夹

Article Immunology

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

Danilo Buonsenso et al.

Summary: This is the first international study to describe a global reduction in the trend of MIS-C incidence during the COVID-19 pandemic. COVID-19 vaccination and other factors possibly linked to the virus itself and/or community transmission may have played a role in preventing new cases of MIS-C.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

添加到收藏夹

Review Pediatrics

Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature

Arianna Dondi et al.

Summary: COVID-19 can present with various skin manifestations in children, and mucocutaneous manifestations may be early signs that physicians should be familiar with.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

添加到收藏夹

Review Pediatrics

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach

Francesca Sperotto et al.

Summary: Initial reports indicated that children were less affected by severe COVID-19 symptoms, but clusters of pediatric cases with severe systemic hyperinflammation and shock linked to COVID-19 have emerged since mid-April 2020. This condition, defined as SARS-CoV-2-associated multisystem inflammatory syndrome in children, shares similarities with Kawasaki disease. Patients often present with persistent fever, gastrointestinal symptoms, rash, conjunctivitis, and mucosal changes, along with elevated inflammatory markers and cytokine storm. Management involves cardiac support, immunomodulation, and anticoagulation during the acute phase, with long-term follow-up crucial due to uncertain prognosis and potential cardiac complications.

EUROPEAN JOURNAL OF PEDIATRICS (2021)

添加到收藏夹

Article Rheumatology

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2

Lauren A. Henderson et al.

Summary: This article provides guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS-C) and hyperinflammation in children with coronavirus disease 2019 (COVID-19). A multidisciplinary Task Force developed 40 guidance statements and a flow diagram for the diagnostic pathway of MIS-C.

ARTHRITIS & RHEUMATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in US Children and Adolescents

Leora R. Feldstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.